Eric M. Meslin is President and CEO of the Council of Canadian Academies (CCA). He joined the CCA in February, 2016, bringing with him more than 25 years of experience in science policy in both university and government settings.
Dr. Meslin came to the CCA from Indiana University (IU), where he was Founding Director of the Indiana University Center for Bioethics for 15 years, Associate Dean for Bioethics in the IU School of Medicine and Professor of Medicine, of Medical & Molecular Genetics, of Bioethics and Law, of Public Health, and of Philosophy. In 2012 Dr. Meslin was appointed IU’s first endowed Professor of Bioethics. He has also held academic positions at the University of Toronto, University of Oxford, as Professor-at-Large at the University of Western Australia, and as the Pierre de Fermat Chaire d’Excellence at the Université de Toulouse. He is currently a Visiting Scholar in the Department of History and Philosophy of Science at the University of Cambridge, and at the Centre of Genomics and Policy at McGill University.
Prior to Indiana, he was Bioethics Research Director of the Ethical, Legal and Social Implications (ELSI) program at the U.S. National Human Genome Research Institute, and then Executive Director of the National Bioethics Advisory Commission appointed by then President Bill Clinton.
Born in Canada, Dr. Meslin received his BA from York University, and his MA and PhD from Georgetown University in Washington D.C. both in philosophy/bioethics. Dr. Meslin has more than 150 published articles and book chapters on various topics in bioethics and science policy. He has been an advisor to domestic and international organizations including the World Health Organization and the Canadian Institutes for Health Research, and sat on committees of the Institute of Medicine (now National Academy of Medicine), the National Institutes of Health, and the Board of Directors of Genome Canada. In 2015 he was appointed Vice-Chair of the UK Biobank Ethics and Governance Council.
Among his honours, Dr. Meslin is a Fellow of the Canadian Academy of Health Sciences, and a Chevalier de L’Order Nationale du Mérite (Knight of the National Order of Merit) for contributions to French bioethics policy.